MENU

NNVC Stock NanoViricides (NNVC, $1.35) Moving Average Convergence Divergence (MACD) Histogram turned negative on November 12, 2024

A.I.dvisor
at Tickeron.com
11/13/24
Loading...
NNVC - NanoViricides
MACD signal
Bearish Trend
Odds of DOWN Trend
Tickeron
MACD signal
Price: $1.35
Daily change: -$0.05 (-3.57%)
Daily volume: 185.7K
Capitalization: $18.8M
Industry: Biotechnology
This is a Bearish indicator signaling NNVC's price could decline from here. Traders may explore shorting the stock or put options. A.I. dvisor identified 52 similar cases where NNVC's MACD histogram became negative, and of them led to successful outcomes. Odds of Success:

NNVC sees MACD Histogram just turned negative

NNVC saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 12, 2024. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 52 instances where the indicator turned negative. In of the 52 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 08, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on NNVC as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 50-day moving average for NNVC moved below the 200-day moving average on October 28, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NNVC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for NNVC entered a downward trend on November 06, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NNVC advanced for three days, in of 202 cases, the price rose further within the following month. The odds of a continued upward trend are .

NNVC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.642) is normal, around the industry mean (14.913). P/E Ratio (0.000) is within average values for comparable stocks, (98.888). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.945). NNVC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (218.764).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. NNVC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NNVC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
NNVC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of anti-viral therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1 Controls Drive
Phone
+1 203 937-6137
Employees
7
Web
http://www.nanoviricides.com